Literature DB >> 10449482

Skin carriage of acinetobacters in Hong Kong.

Y W Chu1, C M Leung, E T Houang, K C Ng, C B Leung, H Y Leung, A F Cheng.   

Abstract

We studied the carriage of Acinetobacter spp. at five superficial sites in 79 patients from two hospitals, in 133 healthy controls from the community (medical students and new nurses), and in 198 student nurses in different classes. A total of 431 isolates from 364 positive sites of 201 subjects and 124 blood culture isolates (1997 to 1998) were genospeciated by amplified ribosomal DNA restriction analysis. Genospecies 3 was the most common species. The carriage rate of student nurses (42 of 131) was significantly lower than that of new nurses from the community (25 of 38) (chi-square test, P = 0.0004; odds ratio [OR], 4.08; 95% confidence limits, 1.78 to 9.41) but not significantly different (P = 0.1) from that of patients in the same hospital (20 of 42). Genospecies from blood cultures and subjects (acute patients and student nurses) from Prince of Wales Hospital were similar to one another but different from subjects from the community or from another hospital (chi-square test, P < 0.0001). Half of the subjects who were positive at at least two sites had different genospecies. Of the 28 sites examined, 68% showed strain variation among isolates of the same genospecies by random amplified polymorphic DNA analysis. Half of the 106 subjects who had samples taken again within 6 weeks or 6 months later were positive only once. In the 17 subjects who were positive on at least two occasions, each occasion yielded different genospecies in 13 subjects. Our results indicate that skin carriage in the majority of healthy subjects is characterized by low density, variation in genospecies and strains, short-term duration, and the typicality of a given locality.

Entities:  

Mesh:

Year:  1999        PMID: 10449482      PMCID: PMC85423     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Delineation of new proteolytic genomic species in the genus Acinetobacter.

Authors:  P J Bouvet; S Jeanjean
Journal:  Res Microbiol       Date:  1989 May-Jun       Impact factor: 3.992

2.  Interspecies transformation of Acinetobacter: genetic evidence for a ubiquitous genus.

Authors:  E Juni
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

3.  Distribution of Acinetobacter species on skin of healthy humans.

Authors:  J Berlau; H Aucken; H Malnick; T Pitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-03       Impact factor: 3.267

4.  Comparative characterization of Acinetobacter strains isolated from different foods and clinical sources.

Authors:  M Gennari; P Lombardi
Journal:  Zentralbl Bakteriol       Date:  1993-11

5.  The distribution of Acinetobacter species in clinical culture materials.

Authors:  H Seifert; R Baginski; A Schulze; G Pulverer
Journal:  Zentralbl Bakteriol       Date:  1993-11

6.  Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin.

Authors:  W E Kloos; M S Musselwhite
Journal:  Appl Microbiol       Date:  1975-09

7.  Clinical strains of Acinetobacter classified by DNA-DNA hybridization.

Authors:  I Tjernberg; J Ursing
Journal:  APMIS       Date:  1989-07       Impact factor: 3.205

Review 8.  Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings.

Authors:  P A Tilley; F J Roberts
Journal:  Clin Infect Dis       Date:  1994-06       Impact factor: 9.079

9.  Identification and biotyping of clinical isolates of Acinetobacter.

Authors:  P J Bouvet; P A Grimont
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Sep-Oct

10.  Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting.

Authors:  M J Struelens; E Carlier; N Maes; E Serruys; W G Quint; A van Belkum
Journal:  J Hosp Infect       Date:  1993-09       Impact factor: 3.926

View more
  23 in total

1.  Molecular characterization of the gene encoding a new AmpC beta-lactamase in a clinical strain of acinetobacter genomic species 3.

Authors:  Alejandro Beceiro; Lourdes Dominguez; Anna Ribera; Jordi Vila; Francisca Molina; Rosa Villanueva; Jose Maria Eiros; German Bou
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

2.  Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups.

Authors:  Nicholas M Anstey; Bart J Currie; Marilyn Hassell; Didier Palmer; Brian Dwyer; Harald Seifert
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.

Authors:  Li-Yueh Huang; Po-Liang Lu; Te-Li Chen; Fang-Yee Chang; Chang-Phone Fung; L K Siu
Journal:  Antimicrob Agents Chemother       Date:  2010-04-05       Impact factor: 5.191

4.  Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong.

Authors:  E T Houang; Y W Chu; C M Leung; K Y Chu; J Berlau; K C Ng; A F Cheng
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

5.  Screening for Acinetobacter baumannii colonization by use of sponges.

Authors:  Yohei Doi; Ezenwa O Onuoha; Jennifer M Adams-Haduch; Diana L Pakstis; Traci L McGaha; Carly A Werner; Bridget N Parker; Maria M Brooks; Kathleen A Shutt; Anthony W Pasculle; Carlene A Muto; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

6.  Recognition of two novel phenons of the genus Acinetobacter among non-glucose-acidifying isolates from human specimens.

Authors:  A Nemec; L Dijkshoorn; P Jezek
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

7.  Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates.

Authors:  Wen-Chien Ko; Nan-Yao Lee; Siou Cing Su; Lenie Dijkshoorn; Mario Vaneechoutte; Li-Rong Wang; Jin-Jou Yan; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

8.  Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii?

Authors:  Anna de Breij; Lenie Dijkshoorn; Ellen Lagendijk; Joke van der Meer; Abraham Koster; Guido Bloemberg; Ron Wolterbeek; Peterhans van den Broek; Peter Nibbering
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

Review 9.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

10.  OXA-207, a novel OXA-24 variant with reduced catalytic efficiency against carbapenems in Acinetobacter pittii from Spain.

Authors:  Rodrigo Cayô; María Merino; Belén Ruiz Del Castillo; María Eliecer Cano; Jorge Calvo; Germán Bou; Luis Martínez-Martínez
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.